Literature DB >> 28810658

Abnormal phenotypic features of IgM+B cell subsets in patients with chronic hepatitis C virus infection.

Fanyun Kong1,2, Bo Feng1, Henghui Zhang1, Huiying Rao1, Jianghua Wang1, Xu Cong1, Lai Wei1.   

Abstract

Hepatitis C virus (HCV) infection is associated with B cell abnormality; however the phenotypic profiles of immunoglobulin (Ig)M+B cell subsets in patients with HCV infection remain unclear. In the current study, the effect of HCV infection on IgM+B cell subsets was evaluated. The percentages, as well as the differentiation and activation features of peripheral IgM+B naive subsets [cluster of differentiation (CD)27-IgM+B cells] and IgM+B memory subsets (CD27+IgM+B cells) were assessed using flow cytometry in 27 patients with chronic hepatitis C (CHC) and 20 healthy controls (HCs). The frequency of CD27+IgM+B memory subsets detected in patients with CHC was significantly higher than that in HCs (P<0.05). Although the frequency of CD27-IgM+B naive subsets was similar in both groups, there was a significantly higher proportion of CD5+B cells detected in the CD27-IgM+B subsets of patients with CHC compared with HCs (P<0.05). Among CD27-IgM+B subsets, abnormal differentiation was associated with HCV infection, with significantly increased percentages of IgD+B cells and CD38+B cells in patients with CHC compared with HCs (P<0.05). In CD27+IgM+B memory subsets, the abnormality of cell differentiation was associated with a significantly increased percentage of CD38+B cells in patients with CHC compared with HCs (P<0.05). In addition, the percentage of activated CD27+IgM+B subsets in patients with CHC were significantly higher than those observed in HCs (P<0.05). The number of CD27-IgD+IgM+B, CD27-CD38+IgM+B and CD27+CD38+IgM+B cells were negatively correlated with HCV RNA in patients with CHC. These results suggest that HCV infection contributes to abnormalities in the percentage, differentiation and activation of IgM+B cell subsets and may disrupt the immune response mediated by IgM+B cells.

Entities:  

Keywords:  activation; differentiation; hepatitis C; immunoglobulin M+B cells

Year:  2017        PMID: 28810658      PMCID: PMC5525653          DOI: 10.3892/etm.2017.4682

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  31 in total

Review 1.  CD38 in T- and B-cell functions.

Authors:  P Deterre; V Berthelier; B Bauvois; A Dalloul; F Schuber; F Lund
Journal:  Chem Immunol       Date:  2000

Review 2.  Human peripheral blood B-cell compartments: a crossroad in B-cell traffic.

Authors:  M Perez-Andres; B Paiva; W G Nieto; A Caraux; A Schmitz; J Almeida; R F Vogt; G E Marti; A C Rawstron; M C Van Zelm; J J M Van Dongen; H E Johnsen; B Klein; A Orfao
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

Review 3.  Contributions of B cells to lupus pathogenesis.

Authors:  Allison Sang; Ying-Yi Zheng; Laurence Morel
Journal:  Mol Immunol       Date:  2013-12-12       Impact factor: 4.407

4.  Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules.

Authors:  Vito Racanelli; Maria Antonia Frassanito; Patrizia Leone; Maria Galiano; Valli De Re; Franco Silvestris; Franco Dammacco
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency.

Authors:  Rita Carsetti; Maria Manuela Rosado; Simona Donnanno; Vanessa Guazzi; Annarosa Soresina; Antonella Meini; Alessandro Plebani; Fernando Aiuti; Isabella Quinti
Journal:  J Allergy Clin Immunol       Date:  2005-02       Impact factor: 10.793

Review 6.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

7.  High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis.

Authors:  J Wang; Y Shan; Z Jiang; J Feng; C Li; L Ma; Y Jiang
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

8.  CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells.

Authors:  Tong Seng Lim; James Kang Hao Goh; Alessandra Mortellaro; Chwee Teck Lim; Günter J Hämmerling; Paola Ricciardi-Castagnoli
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

9.  B cell subsets in atherosclerosis.

Authors:  Heather M Perry; Timothy P Bender; Coleen A McNamara
Journal:  Front Immunol       Date:  2012-12-11       Impact factor: 7.561

10.  Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection.

Authors:  Huiying Rao; Lai Wei; Juan Carlos Lopez-Talavera; Jia Shang; Hong Chen; Jun Li; Qing Xie; Zhiliang Gao; Lei Wang; Jia Wei; Jianning Jiang; Yongtao Sun; Ruifeng Yang; Hong Li; Haiying Zhang; Zuojiong Gong; Lunli Zhang; Longfeng Zhao; Xiaoguang Dou; Junqi Niu; Hong You; Zhi Chen; Qin Ning; Guozhong Gong; Shuhuan Wu; Wei Ji; Qing Mao; Hong Tang; Shuchen Li; Shaofeng Wei; Jian Sun; Jiaji Jiang; Lungen Lu; Jidong Jia; Hui Zhuang
Journal:  J Gastroenterol Hepatol       Date:  2014-03       Impact factor: 4.029

View more
  2 in total

1.  A Role for B Cells to Transmit Hepatitis C Virus Infection.

Authors:  Isabelle Desombere; Freya Van Houtte; Ali Farhoudi; Lieven Verhoye; Caroline Buysschaert; Yvonne Gijbels; Sibyl Couvent; Wilfried Swinnen; Hans Van Vlierberghe; André Elewaut; Andrea Magri; Zania Stamataki; Philip Meuleman; Jane A McKeating; Geert Leroux-Roels
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 8.786

2.  Natural Killer Group 2D Receptor and B1a Cells Crosstalk in Post-Hepatitis C Virus Infection Hepatocellular Carcinoma and Cirrhosis.

Authors:  Reham Hammad; Mona A Eldosoky; Alshaimaa M Mosaad; Asmaa M El-Nasser; Fatma M Kotb; Salwa I Elshennawy; Noha Abdel-Rahman Eldesoky; Mohamed A Selim; Gina G Naguib; Ossama A Ahmed; Mohamed Alboraie; Reda Badr Aglan
Journal:  J Hepatocell Carcinoma       Date:  2022-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.